The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
BACKGROUND
The current study was conducted to compare the overall survival (OS) of concurrent chemoradiotherapy (CCRT) versus radiotherapy (RT) alone in elderly patients (those aged ≥80 years) with muscle‐invasive bladder cancer (MIBC).
METHODS
Patients aged ≥80 years with cT2‐4, N0‐3, M0 transitional cell MIBC who were treated with curative RT (60‐70 Gray) or CCRT were identified in the National...
Objectives Most historic trials demonstrating the outcomes with bladder-preserving radiotherapy (RT) used 64–66 Gy. However, newer data suggest improved outcomes with dose escalation up to 70 Gy. Our objective was to explore the impact of dose escalation on overall survival (OS) and to identify the optimal radiotherapy (RT) dose in patients with muscle-invasive bladder cancer (MIBC) treated with curative...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.